327
Views
28
CrossRef citations to date
0
Altmetric
Research Article

Antioxidant and hepatoprotective effects of silymarin phytosomes compared to milk thistle extract in CCl4 induced hepatotoxicity in rats

, , &
Pages 23-30 | Received 09 Sep 2012, Accepted 29 Apr 2013, Published online: 01 Jul 2013

References

  • Aebi H. Ctalase in vitro. Methods Enzymol, 1984;105:121–6
  • Bares JM, Berger J, Nelson JE, Messner DJ. Silybin treatment is associated with reduction in serum ferritin in patients with chronic hepatitis C. J Clin Gastroenterol, 2008;42:937–44
  • Belfield A, Goldberg D. Alkaline phosphatase colorimetric. M-Enzyme, 1971;12:561
  • Bernhard W, Hoffmann S, Dombrowsky H, Rau GA, Kamlage A, Kappler M, Haitsma JJ, Freihorst J, von der Hardt H, Poets CF. Phosphatidylcholine molecular species in lung surfactant: composition in relation to respiratory rate and lung development. Am J Respir Cell Mol Biol, 2001;25:725–3
  • Broide E, Klinowski E, Koukoulis G, Hadzic N, Portmann B, Baker A, Scapa E, Mieli-Vergani G. Superoxidedismutase activity in children with chronic liver diseases. J Hepatol, 2000;32:188–92
  • Bush RK, Taylor SL, Nordlee JA, Busse WW. Soybean oil is not allergenic to soybean-sensitive individuals. J Allergy Clin Immunol, 1985;76:242–5
  • Das S, Roy P, Auddy RG, Mukherjee A. Silymarin nanoparticle prevents paracetamol-induced hepatotoxicity. Int J Nanomed, 2011;21:1291–301
  • Doumas BT, Watson WA, Biggs HG. Albumin standard and the measurement and the measurement of serum Albumin with bromocresol green. Clin Chim Acta, 1971;31:87–96
  • El-Samaligy MS, Afifi NN, Mahmoud EA. Increasing bioavailability of silymarin using a buccal liposomal delivery system: Preparation and experimental design investigation. Int J Pharm, 2006;308:140–8
  • Esera N, Göçmena C, Erdoğanb S, Büyüknacarc H, Kumcua E, Açıkalınb A, Öndera S. Effect of silymarin on bladder overactivity in cyclophosphamide-induced cystitis rat model. Phytomedicine, 2012;19:840–5
  • European Pharmacopeia 5.0. 2005. Council of Europe, Strasbourg, Codex, France, 2046
  • Everts S, Davis HJ. 1H and 13C NMR of multilamellar dispersions of polyunsaturated (22:6) phospholipids. Biophys J, 2007;79:885–97
  • Freedman ND, Curto TM, Morishima C, Seeffs LB, Goodman ZD, Wright EC, Sinha R, Everhart JE. Silymarin use and liver disease progression in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis trial. Aliment Pharmacol Ther, 2011;33:127–37
  • Giacomelli S, Gallo D, Apollonio P, Ferlini C, Distefano M, Morazzoni P, Riva A, Bombardelli E, Mancuso S, Scambia G. Silybin and its bioavailable phospholipid complex (IdB 1016) potentiate in vitro and in vivo the activity of cisplatin. Life Sci, 2002;70:1447–59
  • Goldberg DM, Spooner RJ. 1983. Assay of glutathione reductase. In: Bergmeyen HV, ed. Methods of enzymatic analysis, 3rd edn. Deerfield Beach: Verlag Chemie, pp. 258–65
  • Gornal AC, Bardawill CJ, David MM. Determination of proteins by means of the biuret reaction. J Biol Chem, 1949;177:751–66
  • Jacobs BP, Dennehy C, Ramirez G, Sapp J, Lawrence VA. Milk thistle for the treatment of liver disease: A systematic review and meta-analysis. Am J Med, 2002;113:506–15
  • Kent C. Regulatory enzymes of phosphatidylcholine biosynthesis: A personal perspective. Biochim Biophys Acta, 2005;1733:53--66
  • Khiralla GM, Salem SA. Biological evaluation of wheat-salty extract, milk-wheat solution and fermented soymilk for treatment of castor-oil induced diarrhea in rats. J Food Res, 2012;1:298–307
  • Křen V, Walterová D. Silybin and silymarin – new effects and applications. Biomed Papers, 2005;149:29–41
  • Lia C, Hsiangb C, Wuc S, Ho T. Identification of novel mechanisms of silymarin on the carbon tetrachloride-induced liver fibrosis in mice by nuclear factor-κB bioluminescent imaging-guided transcriptomic analysis. Food Chem Toxicol, 2012;50:1568–75
  • Lu P, Mamiya T, Lu LL, Mouri A, Zou L, Nagai T, Hiramatsu M, Ikejima T, Nabeshima T. Silibinin prevents amyloid β peptide-induced memory impairment and oxidative stress in mice. Br J Pharmacol, 2009;157:1270–7
  • Malekinejad H, Rezabakhsh A, Rahmani F, Hobbenaghi R. Silymarin regulates the cytochrome P450 3A2 and glutathione peroxides in the liver of streptozotocin-induced diabetic rats. Phytomedicine, 2012;19:583–90
  • Manibusan M, Odin M, Eastmond D. Postulated carbon tetrachloride mode of action. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev, 2007;25:185–209
  • Marczylo TH, Verschoyle RD, Cooke DN, Morazzoni P, Steward WP, Gescher AJ. Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemother Pharmacol, 2007;60:171–7
  • Masini A, Ceccarelli D, Giovannini F, Montosi G, Garuti C, Pietrangelo A. Iron-induced oxidant stress leads to irreversible mitochondrial dysfunctions and fibrosis in the liver of chronic iron-dosed gerbils; the effect of silybin. J Bioenerg Biomembr, 2000;32:175–82
  • Nishikimi M, Roa NA,Yogi K. Measurement of superoxide dismutase. Biochem Bioph Res Common, 1972;46:849–54
  • Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med, 1967;70:158–69
  • Pang B, Bi S, Yan Y, Wang T. Investigation on the interactions of silymarin to bovine serum albumin and lysozyme by fluorescence and absorbance. J Lumin, 2012;132:895–900
  • Paschke A, Zunker K, Wigotzki M, Steinhart H. Determination of the IgE-binding activity of soy lecithin and refined and non-refined soybean oils. J Chromat B: Biomed Sci Appl, 2001;756:249–54
  • Popova AV, Hincha DK. Intermolecular interactions in dry rehydrated pure and mixed bilayers of phosphatidylcholine and digerlacto syldiacylglycrol: A Fourier transform infrared spectroscopy study. Biophys J, 2003;85:1682–90
  • Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Amer J Clin Pathol, 1957;28:56–63
  • Semalty A, Semalty M, Singh M, Rawat M, Franceschi F. Supramolecular phospholipids–polyphenolics interactions: The PHYTOSOME® strategy to improve the bioavailability of phytochemicals. Fitoterapia, 2010;81:306–14
  • Sharma S, Sikarwar M. Phytosome: A review. Planta Indica, 2005;2:1–3
  • Singh PR, Tyagi A, Sharma G, Mohan S, Agarwal R. Oral silybin inhibits in vivo human bladder tumor growth involving down-regulation of survivin. Clin Cancer Res, 2008;14:300–8
  • Singh PR, Raina K, Deep G, Chan D, Agarwal R. Silybin suppresses growth of human prostate carcinoma pc3 orthotopic xenograft via activation of extracellular signal-regulated kinase 1/2 and inhibition of signal transducers and activators of transcription signaling. Clin Cancer Res, 2009;15:613–21
  • Södergren E, Cederberg J, Vessby B, Basu S. Vitamin E reduces lipid peroxidation in experimental hepatotoxicity in rats. Eur J Nutr, 2001;40:6–10
  • Sonai D, Tejal S, Vaischali T, Tejal G. Silymarin – solid dispersions: Characterization and influence of preparation methods on dissolution. Acta Pharm, 2010;60:427–43
  • Syn-Cordero A, Graf NT, Nakanishi Y, Wani CM, Agarwal R, Kroll JD, Oberlies HN. Large-scale isolation of flavonolignans from Silybum marianum (milk thistle) extract affords new minor constituents and preliminary structure-activity relationships. Planta Med, 2010;76:644–7
  • Vermehren C, Johansen PB, Hansen HS, Vermehren C. Absorption and metabolism of the absorption enhancer didecanoylphosphatidylcholine in rabbit nasal epithelium in vivo. Drug Metab Dispos, 1997;9:1083–8
  • Tiwari P, Kumar K, Pandey KA, Pandey A, Sahu KP. Antihepatotoxic activity of Euophorbia hirta and Boerhaavia diffusa extracts on some experimental models of liver injury in rats. Int J Innovat Pharm Res, 2011;2:126–30
  • Wellington K, Jarvis B. Silymarin: A review of its clinical properties in the management of hepatic disorders. Bio Drugs, 2001;15:465–89
  • Yan JJ, Jung JS, Lee JE, Lee J, Huh SO, Kim HS, Jung KC, Cho JY, Nam JS, Suh HO, et al. Therapeutic effects of lysophosphatidylcholine in experimental sepsis. Nat Med, 2004;10:161--7
  • Yanyu X, Yunmei S, Zhipeng C, Qineng P. The preparation of silybin–phospholipid complex and the study on its pharmacokinetics in rats. Int J Pharm, 2006;307:77–82
  • Zangar RC, Benson JM, Burnett VL, Springer DL. Cytochrome P450 2E1 is the primary enzyme responsible for low-dose carbon tetrachloride metabolism in human liver microsomes. Chem Biol Interact, 2000;125:233–43

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.